VLife provides high performance, accurate and reliable solutions for improving productivity in drug and molecular discovery. VLife's products are benchmarked as 'Best in Class' for a wide spectrum of critical research objectives and functionalities. VLife products ensure that researchers get 'All applications for a specific domain in one product'. If a researcher is focused on: 1.QSAR only, all they have to license in is the QSARProâ„¢ 2.Protein modeling and Docking, BioPredictaâ„¢ is all one needs 3.Cheminformatics, then product of choice is ChemXplorâ„¢ 4.If the scientists' interest is across CADD workspace, they can license VLifeMDSâ„¢; the comprehensive flagship product of VLife

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Arla Foods AmbA manufactures and distributes dairy products. The firm produces dairy ingredients and bacterial cultures for food manufacturers and for agricultural use. It offers Lurpak and Castello brands. The company was founded in 1881 and is headquartered in Viby, Denmark.

BIOPHARM Gesellschaft zur biotechnologischen Entwicklung is a German private company located in Eppelheim. The firm operates as a biotechnology development company. It was founded in 1986 by Michael Paulista, he has been the CEO since the inception date.\nThe company says this about itself: BIOPHARM is one of the pioneers in the research and development of biotechnological drug substances. Our platform technology of recombinant human growth factors combines our expertise and experience of more than 30 years with innovative applications in the field of orthopedics, dermatology and personalized medicine.

Institut de Recherche pour le Développement operates as a scientific and technical public institution which provides information, expertise, support and training in production performance. It performs research centered on the relationship between human beings and its environment in intertropical areas. In that context the IRD implements research projects on sleeping sickness and the vectors transmitting the disease. The company is headquartered in Marseille, France.

Jiangsu Kanion Pharma is a pharmaceuticals company based out of LIANYUNGANG. Jiangsu Kanion Pharma representatives, don’t miss out on opportunities to build relationships with members on LinkedIn. Claim your page, write a simple description, and share content to attract followers that can lead to new customers, brand fans, and future employees.

Urgo is a mobile app that connects users in need of services with local professionals that can perform them. Urgo's vision is be the marketplace for connecting customers in need of services with local professionals. Urgo Walkthrough: -A customer posts a service needed done -Local professional will get a notification of posting based on specialty -Professionals gives the customer a quote -The customer picks best professional based on price quoted, reviews, and qualifications.

Solar Light Co., Inc. engages in manufacturing of precision ultraviolet light sources, solar simulators, and radiometers. The firm provides accelerated ultraviolent testing and light source spectral measurement services. Its products include light sensors, light meters and transmittance analyzers. The company was founded in 1967 and is headquartered in Glenside, PA.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Yunnan Lunyang Technology Co., Ltd., established on 2018-11-01, Business scope includes research and development of computer software and hardware,Application and Technical Consulting,Technical Services,technology transfer;Biotechnology Extension Services;Agriculture, forestry, animal husbandry and fishery technology extension services;Environmental protection technology promotion service,Energy-saving technology promotion service,New energy technology promotion service;Domestic Trade,Material supply and marketing(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Henan Dongpeptide Biological Co., Ltd., established on 2016-06-16, Business scope includes general items:Research and development of bio-based materials technology;Biochemical product technology research and development;Manufacturing of bio-based materials;Manufacturing of daily chemical products;Business Management Consulting;Purchase of primary agricultural products;Grain Purchase;Import and export;Technology Import and Export;Food import and export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:beverage production;Health food production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Nanjing Drum Tower Hospital is a private company headquartered in China. The firm provides medical services.

CytRx is a biopharmaceutical research and development company specializing in oncology. The CytRx oncology pipeline is focused on the clinical development of aldoxorubicin (formerly known as INNO-206), its improved version of the widely used chemotherapeutic agent doxorubicin. CytRx has initiated an international Phase 2b clinical trial as a treatment for soft tissue sarcomas, has completed its Phase 1b/2 clinical trial primarily in the same indication, and has initiated a Phase 1b pharmacokinetics clinical trial in patients with metastatic solid tumors and a Phase 1b study of aldoxorubicin in combination with doxorubicin in patients with advanced solid tumors. The Company is initiating a Phase 3 pivotal trial under a special protocol assessment (SPA) with aldoxorubicin as a therapy for patients with soft tissue sarcomas whose tumors have progressed following treatment with chemotherapy. CytRx is expanding its pipeline of oncology candidates based on a novel linker platform technology that can be utilized with multiple chemotherapeutic agents and could allow for greater concentration of drug at tumor sites. The Company also has rights to two additional drug candidates, tamibarotene and bafetinib. The Company completed its evaluation of bafetinib in the ENABLE Phase 2 clinical trial in high-risk B-cell chronic lymphocytic leukemia (B-CLL), and plans to seek a partner for further development of bafetinib, and is evaluating further development of tamibarotene.

WoundKair Concepts is a wound care technology company that offers wound care products and medical devices.

Anterogen Co., Ltd. engages in the development and sale of stem cell therapy treatments. Its products include Cupistem and Remodullin injection, Queencell, and stem cell conditioned media. It also offers stem cell banking and analysis services. The company was founded on March 16, 2000 and is headquartered in Seoul, South Korea.

Nanjing Gulou Hospital is a Chinese private company located in Nanjing. The firm operates as a hospital.